Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Clas Malmestrom"'
Autor:
Igal Rosenstein, Lenka Novakova, Hlin Kvartsberg, Anna Nordin, Sofia Rasch, Elzbieta Rembeza, Sofia Sandgren, Clas Malmeström, Stefanie Fruhwürth, Markus Axelsson, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-12 (2024)
Abstract Background The Gas6/TAM (Tyro3, Axl, and Mer) receptor system has been implicated in demyelination and delayed remyelination in experimental animal models, but data in humans are scarce. We aimed to investigate the role of Gas6/TAM in neurod
Externí odkaz:
https://doaj.org/article/03a9f4ad029b4835b686b9955f7699c1
Autor:
Magnus Johnsson, Fredrik Asztely, Susanne Hejnebo, Markus Axelsson, Clas Malmeström, Torbjörn Olausson, Jan Lycke
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 9, Iss 8, Pp 1296-1301 (2022)
Abstract SARS‐COV‐2 frequently cause neurological disorders and is sometimes associated with onset of autoimmune diseases affecting the nervous system. Over recent years, a rare but distinct diagnosis designated myelin oligodendrocyte glycoprotei
Externí odkaz:
https://doaj.org/article/7ac733ed610b493fae51ca6944200cbe
Publikováno v:
Brain and Behavior, Vol 9, Iss 11, Pp n/a-n/a (2019)
Abstract Objectives Immunotherapy in addition to antiepileptic drugs can improve seizure freedom rates in autoimmune epilepsy, highlighting the importance of early diagnosis. A diagnosis of autoimmune epilepsy can be supported by presence of serum an
Externí odkaz:
https://doaj.org/article/135895d14b5840dc9295a5f7f708d372
Autor:
Lenka Novakova, Markus Axelsson, Clas Malmeström, Henrik Imberg, Olle Elias, Henrik Zetterberg, Olle Nerman, Jan Lycke
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194828 (2018)
Neurodegeneration occurs during the early stages of multiple sclerosis. It is an essential, devastating part of the pathophysiology. Tools for measuring the degree of neurodegeneration could improve diagnostics and patient characterization.This study
Externí odkaz:
https://doaj.org/article/0b948e9eff2041baba3127d71258438e
Autor:
Sapna Sharma, Clas Malmeström, Christopher Lindberg, Sarah Meisel, Karin Schön, Martina Verolin, Nils Yngve Lycke
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Myasthenia gravis (MG) is an autoimmune neurological disorder typified by skeletal muscle fatigue and most often production of autoantibodies against the nicotinic acetylcholine receptor (AChR). The present study was undertaken to assess the extent o
Externí odkaz:
https://doaj.org/article/da7474ec71454b1281bb8a3cb4f8cf89
Autor:
Avadhesh Kumar Singh, Lenka Novakova, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke, Susanna L. Cardell
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
We have identified a population of T lymphocytes in peripheral blood, Vδ1 TCRγδ T lymphocytes, which unexpectedly was uniquely expressing high production of interferon-γ in newly diagnosed, untreated multiple sclerosis (MS) patients. IFN-γ produ
Externí odkaz:
https://doaj.org/article/d213688dea244507abe0917a33bfbfa2
Autor:
Sofia Sandgren, Lenka Novakova, Markus Axelsson, Firoozeh Amirbeagi, Ingrid Kockum, Tomas Olsson, Clas Malmestrom, Jan Lycke
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundAlemtuzumab (ALZ) is an immune reconstitution therapy for treating relapsing-remitting multiple sclerosis (RRMS). However, ALZ increases the risk of secondary autoimmune diseases (SADs).ObjectiveWe explored whether the detection of autoimmu
Externí odkaz:
https://doaj.org/article/57d02a89c1f745458ba0c6a29dfd6ed3
Autor:
Sofia Sandgren, Lenka Novakova, Anna Nordin, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundAlemtuzumab (ALZ) is a pulsed immune reconstitution therapy for multiple sclerosis (MS).ObjectiveTo assess basic characteristics, therapeutic effects, and prognostic biomarkers on clinical and imaging parameters of disease activity for rela
Externí odkaz:
https://doaj.org/article/1a51aa49d87b4da59edc2051d2fd6490